Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ketamine as an Adjunctive Therapy for Major Depression - a Randomised Controlled Pilot Trial: The KARMA-Dep Trial

NCT03256162 is registered in ClinicalTrials.gov with St Patrick's Hospital, Ireland as lead sponsor.

NCT NCT03256162
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03256162 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ketamine as an Adjunctive Therapy for Major Depression - a Randomised Controlled Pilot Trial: The KARMA-Dep Trial
Lead sponsor
St Patrick's Hospital, Ireland
Phase
Phase 1
Overall status
Completed
Start date
September 7, 2017
Completion date
September 21, 2018
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar depression, major depressive episode, unipolar depression